P2RY12 and myocardial infarction: The incidence of bleeding events within the first 48 h of MI hospitalization was 4.5%, and the incidence of MACE within the first 48 h was 6.3%, both lower when compared to patients who were not transitioned to an oral P2Y12 inhibitor.25